These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Guidelines for treating depression using non-selective serotonin reuptake inhibitors. Withersty DJ; Vanin JR W V Med J; 1999; 95(1):20-3. PubMed ID: 9949692 [TBL] [Abstract][Full Text] [Related]
8. [Panic and depression: early diagnosis of patients at risk, early treatment with an SSRI (Selective Serotonin Reuptake Inhibitor)]. Psychiatr Prax; 1997 Sep; 24(5 Suppl):1-4. PubMed ID: 9361703 [No Abstract] [Full Text] [Related]
9. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Perry PJ J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647 [TBL] [Abstract][Full Text] [Related]
10. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram. Raskin J; George T; Granger RE; Hussain N; Zhao GW; Marangell LB J Psychiatr Res; 2012 May; 46(5):667-74. PubMed ID: 22410206 [TBL] [Abstract][Full Text] [Related]
13. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression]. Weimer E; Braus DF; Cavus I; Thome J Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
15. [Therapy with selective serotonin reuptake inhibitors (SSRI). Indications, uses and risks]. Ebert D Fortschr Med; 1996 Jul; 114(18-19):243-7. PubMed ID: 8766793 [TBL] [Abstract][Full Text] [Related]
16. Platelet serotonin reuptake inhibition and response to SSRIs in depressed adolescents. Axelson DA; Perel JM; Birmaher B; Rudolph G; Nuss S; Yurasits L; Bridge J; Brent DA Am J Psychiatry; 2005 Apr; 162(4):802-4. PubMed ID: 15800159 [TBL] [Abstract][Full Text] [Related]
17. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. Garland EJ; Baerg EA J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958 [TBL] [Abstract][Full Text] [Related]
18. Treating depression with selective serotonin reuptake inhibitors: a practical approach. Sampson SM Mayo Clin Proc; 2001 Jul; 76(7):739-44. PubMed ID: 11444407 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062 [TBL] [Abstract][Full Text] [Related]
20. Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review. Regan KL J Cardiovasc Nurs; 2008; 23(6):489-96. PubMed ID: 18953212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]